Inhibitory effect of a novel phosphodiesterase IV inhibitor, T-440 on antigen-and chemical mediator-induced bronchoconstriction in guinea pigs (in vivo)
-
- Kaminuma Osamu
- <I>Lead</I> Optimization Research Laboratory, Tanabe Seiyaku Co., Ltd.
-
- Kikkawa Hideo
- <I>Lead</I> Optimization Research Laboratory, Tanabe Seiyaku Co., Ltd.
-
- Matsubara Shigeki
- <I>Lead</I> Optimization Research Laboratory, Tanabe Seiyaku Co., Ltd.
-
- Ikezawa Katsuo
- <I>Lead</I> Optimization Research Laboratory, Tanabe Seiyaku Co., Ltd.
書誌事項
- タイトル別名
-
- Inhibitory Effect of a Novel Phosphodiesterase IV Inhibitor, T-440, on Antigen- and Chemical Mediator-Induced Bronchoconstrictions in Guinea Pigs In Vivo.
この論文をさがす
抄録
We demonstrated the effect of a novel selective type IV phosphodiesterase (PDE) IV inhibitor, T-440 (1-[1-(2-methoxyethyl)pyrid-2-one-4-yl]-2, 3-bis(hydroxymethyl)-6, 7-diethoxynaphthalene), on antigen- and chemical mediator-induced bronchoconstrictions in anesthetized guinea pigs in vivo. Intravenously (i. v.) administered T-440 inhibited antigen-induced bronchoconstriction dose-dependently in passively sensitized guinea pigs (ED50= 2.3 mg/kg). Histamine-, leukotriene (LT) D4-, U-46619-, acetylcholine (ACh)-, neurokinin A- and endothelin-1-induced bronchoconstrictions were also inhibited by i. v. injected T-440. Most potent suppression was produced against the bronchoconstriction induced by LTD4(ED50= 0.89 μg/kg), whereas the effect against ACh was very weak (ED50= 1.8 mg/kg). Additionally, T-440 inhibited histamine-induced bronchoconstriction by intraduodenal and intratracheal administration (ED50and EC50= 1.6mg/kg and 0.50mg/ml, respectively). Bronchoconstrictions induced by antigen and chemical mediators were also suppressed by theophylline. However, all of these anti-spasmolyiic effects of theophylline were less potent than those of T-440 (1.8-110times). Our results indicate the importance of PDE IV in bronchodilation, and PDE IV inhibitors may have potential as anti-asthma drugs.
収録刊行物
-
- Jpn.J.Pharmacol.
-
Jpn.J.Pharmacol. 72 (1), 1-8, 1996
公益社団法人 日本薬理学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390001204286344192
-
- NII論文ID
- 10008675480
-
- NII書誌ID
- AA00691188
-
- DOI
- 10.1254/jjp.72.1
-
- COI
- 1:CAS:528:DyaK28Xlsl2gurY%3D
-
- ISSN
- 13473506
- 00215198
-
- PubMed
- 8902593
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- Crossref
- PubMed
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可